Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dexcom Inc
(NQ:
DXCM
)
138.01
+0.14 (+0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,203,214
Open
138.91
Bid (Size)
128.81 (1)
Ask (Size)
130.00 (5)
Prev. Close
137.87
Today's Range
134.39 - 139.24
52wk Range
74.75 - 142.00
Shares Outstanding
96,748,901
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
DXCM stock results show that DexCom beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
Performance
YTD
+12.12%
+12.12%
1 Month
-1.37%
-1.37%
3 Month
+9.09%
+9.09%
6 Month
+70.19%
+70.19%
1 Year
+10.47%
+10.47%
More News
Read More
Peering Into DexCom's Recent Short Interest
April 25, 2024
Via
Benzinga
Dexcom Beats First-Quarter Views And Raises Sales Outlook, But Shares Crumble
April 25, 2024
Via
Investor's Business Daily
Dexcom Reports First Quarter 2024 Financial Results
April 25, 2024
From
DexCom, Inc.
Via
Business Wire
$1000 Invested In DexCom 5 Years Ago Would Be Worth This Much Today
April 17, 2024
Via
Benzinga
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
April 11, 2024
Via
Chartmill
The Analyst Verdict: DexCom In The Eyes Of 4 Experts
April 10, 2024
Via
Benzinga
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
April 25, 2024
Via
Investor's Business Daily
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
April 20, 2024
Via
Talk Markets
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
April 18, 2024
Via
Investor's Business Daily
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
April 17, 2024
Via
InvestorPlace
Topics
ETFs
Disruptive Forces: 3 Game-changing Stocks Reshaping the Tech Landscape
April 13, 2024
Via
InvestorPlace
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
April 12, 2024
Via
Investor's Business Daily
Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In
April 10, 2024
Via
InvestorPlace
3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild
April 10, 2024
Via
InvestorPlace
DexCom Stock Sees IBD Stock Market Rating Sweetens Ups; Earns 83 RS Rating
April 08, 2024
Via
Investor's Business Daily
2 Growth Stocks to Buy Hand Over Fist in April
April 08, 2024
Via
The Motley Fool
7 Nasdaq Stocks to Sell in April Before They Crash & Burn
April 03, 2024
Via
InvestorPlace
Dexcom Publishes Annual Sustainability Report
April 03, 2024
From
DexCom, Inc.
Via
Business Wire
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
April 02, 2024
From
DexCom, Inc.
Via
Business Wire
DexCom Stock Gains from GLP-1 Diabetic Users
April 02, 2024
Via
MarketBeat
3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List
April 01, 2024
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Micron, Dropbox And 2 Other Stocks Insiders Are Selling
April 01, 2024
Via
Benzinga
Market Cap Game Show: Andy Cross vs. Bill Mann
March 30, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.